APAC Healthcare Weekly (Aug 3)– Celltrion, Alteogen, Wuxi Bio, CSPC, Jiangsu Hengrui, Eisai, Kissei
Celltrion is acquiring a biopharmaceutical production plant in US. Wuxi Bio starts construction of new facility. CSPC and Jiangsu Hengrui stuck...
611 Views
Energy Medicine. Personal Experience. Impact. Growth in Asia. Ideas
This is an invest-able idea at the private level  with long term benefits. Both for the body, and for other ideas as well.Ever since I turned over...
4k Views
Can Innovation labs be assessed to pick stocks for your portfolio?
Companies across different industries are building Innovation centers in Singapore, Hong Kong and other cities across Asia and the rest of the...
936 Views
Hutchison Whampoa Restructuring: Next Move for Watson's?
The announced restructuring of Cheung Kong Limited and Hutchison Whampoa Limited has been well received on the HKEx. Hutchison shares have rallied...
654 Views
SciClone Pharma (6600 HK): GL Capital’s Scheme Offer at HK$18.80
The offer price has been declared final. It is reasonable, aligning with the all-time high and the IPO price. This is a done deal.
941 Views